a43f31b272
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
3.5 KiB
3.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO DIABETES. | This Act directs the Division of Medicaid and Medical Assistance, Division of Public Health, and Office of Management and Budget – Human Resources Management (“the Agencies”) to report to the General Assembly every 2 years the impacts and costs associated with diabetes. The first report is due by June 30, 2019. The report shall include: | us/states/de | Delaware General Assembly | 149 | HB 203 | Delaware HB 203 (149) |
|
enacted |
|
1 | 7 | 2 | 2017-06-01 | 2017-09-14 | openstates | ocd-bill/34e0c39d-0dae-4cea-b687-4235d863ffe3 | https://legis.delaware.gov/BillDetail?LegislationId=25862 | 8c91dae784d698eca6d145b180f2bed67a41c6fd4f30d885feb5ce401438d58e | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware HB 203 (149) — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO DIABETES.
This Act directs the Division of Medicaid and Medical Assistance, Division of Public Health, and Office of Management and Budget – Human Resources Management (“the Agencies”) to report to the General Assembly every 2 years the impacts and costs associated with diabetes. The first report is due by June 30, 2019. The report shall include:
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Bill Text (committee substitute) — source
Votes
- SM — 20–0 (pass) · upper
- SM — 38–0 (pass) · lower
Sponsors
- Helene M. Keeley — primary (person)
- Margaret Rose Henry — primary (person)
- Michael Mulrooney — primary (person)
- Stephanie T. Bolden — primary (person)
- Charles Potter Jr. — cosponsor (person)
- Deborah Hudson — cosponsor (person)
- James Johnson — cosponsor (person)
- John L. Mitchell — cosponsor (person)
- Ruth Briggs King — cosponsor (person)
- Timothy D. Dukes — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2017-06-01 Introduced and Assigned to Health & Human Development Committee in House
introduction, referral-committee - 2017-06-14 Reported Out of Committee (Health & Human Development) in House with 12 On Its Merits
committee-passage - 2017-06-27 Passed By House. Votes: 38 YES 3 ABSENT
passage - 2017-06-27 Assigned to Health, Children & Social Services Committee in Senate
introduction, referral-committee - 2017-06-30 Reported Out of Committee (Health, Children & Social Services) in Senate with 3 On Its Merits
committee-passage - 2017-07-02 Passed By Senate. Votes: 20 YES 1 ABSENT
passage - 2017-09-14 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/34e0c39d-0dae-4cea-b687-4235d863ffe3. Confidence: reported (aggregated from official Delaware legislature records).